• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Untrusto Commercial





















One of the most important comments on deceit, I think, was made by Adam Smith. He pointed out that a major goal of business is to deceive and oppress the public.

And one of the striking features of the modern period is the institutionalization of that process, so that we now have huge industries deceiving the public — and they're very conscious about it, the public relations industry. Interestingly, this developed in the freest countries—in Britain and the US — roughly around time of WWI, when it was recognized that enough freedom had been won that people could no longer be controlled by force. So modes of deception and manipulation had to be developed in order to keep them under control.
 




One of the most important comments on deceit, I think, was made by Adam Smith. He pointed out that a major goal of business is to deceive and oppress the public.

And one of the striking features of the modern period is the institutionalization of that process, so that we now have huge industries deceiving the public — and they're very conscious about it, the public relations industry. Interestingly, this developed in the freest countries—in Britain and the US — roughly around time of WWI, when it was recognized that enough freedom had been won that people could no longer be controlled by force. So modes of deception and manipulation had to be developed in order to keep them under control.

I'm sure Novartis never intentionally meant to invoke fear in patients that their physicians aren't managing there CHF condition appropriately. Plus, who cares that it may question the treatment approach or current therapy that a physician uses. Remember, Novartis care about customers!
 




I'm sure Novartis never intentionally meant to invoke fear in patients that their physicians aren't managing there CHF condition appropriately. Plus, who cares that it may question the treatment approach or current therapy that a physician uses. Remember, Novartis care about customers!

which customers?